• New software from UHasselt and ZEISS shows in sharp detail how biomolecules move in cells.

    22 hours ago

  • Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024

    23 hours ago

  • VIB-KU Leuven study reveals FUS protein’s role in ALS and FTD

    Friday June 14th 2024

  • Mithra sells Estetra SRL, Neuralis SA and specific assets to Gedeon Richter

    Wednesday June 12th 2024

  • Mithra files for bankruptcy and continues negotiations with Gedeon Richter for the sale of Neuralis and Estetra

    Monday June 10th 2024

  • The importance of a disturbed lipid metabolism in Charcot-Marie-Tooth disease

    Tuesday June 4th 2024

  • Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response

    Monday June 3rd 2024

  • Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications

    Friday May 31st 2024

  • Your news here?

  • reMYND announces publication in Science of novel drug target with potential for development into transformative treatments for Alzheimer’s disease

    Thursday May 30th 2024

  • Waste2Func Video Release: The technology is ready, are we?

    Friday May 24th 2024

  • BIO INX and Readily3D Announce Collaboration to Advance Volumetric Bioprinting with Cutting-edge Gel-MA Based Ink

    Wednesday May 22nd 2024

Strategic Partners